✨
AI Summary
- Merck pushes Terns and other deals; Boehringer warns on Europe's innovation climate.
- Kelun-Merck agreement reshapes China's deal-making landscape.
- Neuroscience R&D revival and new LDL-C guidelines impact drug costs.